Benzoxazolines

Medchemexpress LLC 2-(4-oxo-1,2,3-benzotriazin-3-yl)-N-[(1S)-1-[4-(trifluoromethoxy)phenyl]ethyl]acetamide | 1929519-13-0 | MFCD32858822 | 99.9% | 392.33 g·mol^-1 | C18H15F3N4O3 | 5 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

Zelatriazin is a selective GPR139 agonist provided for research use to study GPR139-mediated signaling and potential treatments for negative symptoms of schizophrenia. Supplied as a high-purity solid, it includes validated activity and stability information suitable for in vitro and in vivo laboratory workflows.

• Selective GPR139 agonist with EC50 ≈ 22 nM.
• High purity (≈99.9%) suitable for research assays.
• Molecular formula C18H15F3N4O3; molecular weight 392.33 g·mol^-1.
• Available in small research sizes (for example, 5 mg).
• Powder stability: -20°C up to 3 years; 4°C up to 2 years.
• Solvent solution stability: -80°C up to 6 months; -20°C up to 1 month.
• For research use only; not for human or clinical use.

Medchemexpress LLC 2-(4-oxo-1,2,3-benzotriazin-3-yl)-N-[(1S)-1-[4-(trifluoromethoxy)phenyl]ethyl]acetamide | 1929519-13-0 | MFCD32858822 | 99.9% | C18H15F3N4O3 | 10MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

Zelatriazin is a potent, selective small-molecule GPR139 agonist supplied for research use. It exhibits reported activity (EC50 ≈ 22 nM) and is provided as a purified compound for in vitro and preclinical pharmacology studies; formulations include solid vials and ready-to-use DMSO solutions.

• Potent GPR139 agonist (EC50 ≈ 22 nM).
• High purity (~99.9%).
• Molecular formula C18H15F3N4O3; mol wt 392.3 g/mol.
• Available as solid and DMSO solution formats.
• Intended for research use only; not for human or veterinary use.